Detalhe da pesquisa
1.
Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union.
Health Qual Life Outcomes
; 12: 104, 2014 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24989428